In this DHCG Disruptive Dose, Mark Bard speaks with Ezra Suveyke CPO/CTO at PulsePoint about balancing data innovation with privacy in healthcare marketing. Suveyke outlines the complex regulatory landscape facing marketers, from HIPAA and NAI guidelines to increasingly restrictive state legislation. He emphasizes that consent is becoming the central framework for all data decisions, requiring marketers to understand not just if they can target an audience but when and where it’s appropriate to do so. The conversation explores the crucial distinction between technical capabilities and ethical implementation. Suveyke shares a balanced perspective as both technologist and patient, suggesting that when healthcare marketing is done with genuine intent to help—providing relevant information that saves time and improves outcomes—it creates positive experiences that benefit everyone in the ecosystem.